Metastatic Clear-cell Renal Cell Carcinoma With a Long-term Response to Sunitinib: A Distinct Phenotype Independently Associated With Low PD-L1 Expression.
Kammerer-Jacquet, Solène-Florence
Metastatic Clear-cell Renal Cell Carcinoma With a Long-term Response to Sunitinib: A Distinct Phenotype Independently Associated With Low PD-L1 Expression. [electronic resource] - Clinical genitourinary cancer 06 2019 - 169-176.e1 p. digital
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
1938-0682
10.1016/j.clgc.2019.01.014 doi
Adult
Aged
Aged, 80 and over
B7-H1 Antigen--metabolism
Carcinoma, Renal Cell--drug therapy
Disease Progression
Down-Regulation
Female
Gene Expression Regulation, Neoplastic
Humans
Kidney Neoplasms--drug therapy
Liver Neoplasms--drug therapy
Male
Middle Aged
Neoplasm Metastasis
Phenotype
Retrospective Studies
Sunitinib--administration & dosage
Survival Analysis
Treatment Outcome
Von Hippel-Lindau Tumor Suppressor Protein--genetics
Metastatic Clear-cell Renal Cell Carcinoma With a Long-term Response to Sunitinib: A Distinct Phenotype Independently Associated With Low PD-L1 Expression. [electronic resource] - Clinical genitourinary cancer 06 2019 - 169-176.e1 p. digital
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
1938-0682
10.1016/j.clgc.2019.01.014 doi
Adult
Aged
Aged, 80 and over
B7-H1 Antigen--metabolism
Carcinoma, Renal Cell--drug therapy
Disease Progression
Down-Regulation
Female
Gene Expression Regulation, Neoplastic
Humans
Kidney Neoplasms--drug therapy
Liver Neoplasms--drug therapy
Male
Middle Aged
Neoplasm Metastasis
Phenotype
Retrospective Studies
Sunitinib--administration & dosage
Survival Analysis
Treatment Outcome
Von Hippel-Lindau Tumor Suppressor Protein--genetics